摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-<(quinolin-3-ylcarbonyl)amino>-1H-indole-2-carboxylic acid | 224321-37-3

中文名称
——
中文别名
——
英文名称
5-<(quinolin-3-ylcarbonyl)amino>-1H-indole-2-carboxylic acid
英文别名
5-(quinoline-3-carbonylamino)-1H-indole-2-carboxylic acid
5-<(quinolin-3-ylcarbonyl)amino>-1H-indole-2-carboxylic acid化学式
CAS
224321-37-3
化学式
C19H13N3O3
mdl
——
分子量
331.331
InChiKey
DMTWFWNNPFZRCC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    25
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    95.1
  • 氢给体数:
    3
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Methyl 8-(chloromethyl)-4-hydroxy-2-(trifluoromethyl)-3,6,7,8-tetrahydropyrrolo[3,2-e]indol-6-ium-1-carboxylate;chloride 、 5-<(quinolin-3-ylcarbonyl)amino>-1H-indole-2-carboxylic acid盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 dl-methyl 4-chloromethyl-8-hydroxy-6-<5-<(quinolin-3-ylcarbonyl)amino>-1H-indol-2-ylcarbonyl>-2-trifluoromethyl-1,4,5,6-tetrahydropyrrolo<3,2-e>indole-3-carboxylate
    参考文献:
    名称:
    Novel Cyclopropapyrroloindole Derivative (AT-3510) Bearing Methoxycarbonyl and Trifluoromethyl Groups
    摘要:
    The seco-Cl 3-methoxycarbonyl-2-trifluoromethylcyclopropapyrroloindole (MCTFCPI) derivatives dl- and/or (S)-10 carrying various acyl moieties at the NG-position were synthesized along with their prodrugs (S)-12, and their antitumor activity was evaluated. Among these derivatives, AT-3510 [(S)-12m], the novel prodrug MCTFCPI derivative carrying a 5-(7-methoxybenzofuran-2-ylcarbonyl)aminoindole-2-carbonyl group at the NG-position, was found to exhibit more excellent antitumor activity against human tumor xenografts than the clinical trial candidates carzelesin (6) and KW-2189 (7) and cisplatin.
    DOI:
    10.1021/jm980668c
  • 作为产物:
    参考文献:
    名称:
    Novel Cyclopropapyrroloindole Derivative (AT-3510) Bearing Methoxycarbonyl and Trifluoromethyl Groups
    摘要:
    The seco-Cl 3-methoxycarbonyl-2-trifluoromethylcyclopropapyrroloindole (MCTFCPI) derivatives dl- and/or (S)-10 carrying various acyl moieties at the NG-position were synthesized along with their prodrugs (S)-12, and their antitumor activity was evaluated. Among these derivatives, AT-3510 [(S)-12m], the novel prodrug MCTFCPI derivative carrying a 5-(7-methoxybenzofuran-2-ylcarbonyl)aminoindole-2-carbonyl group at the NG-position, was found to exhibit more excellent antitumor activity against human tumor xenografts than the clinical trial candidates carzelesin (6) and KW-2189 (7) and cisplatin.
    DOI:
    10.1021/jm980668c
点击查看最新优质反应信息

文献信息

  • TRIFLUOROMETHYLPYRROLOINDOLE CARBOXYLIC ESTER DERIVATIVE AND PROCESS FOR PRODUCING THE SAME
    申请人:KYORIN PHARMACEUTICAL CO., LTD.
    公开号:EP0656360A1
    公开(公告)日:1995-06-07
    Trifluoromethylpyrroloindole carboxylic ester derivatives represented by general formulae (1) and (2) having an antitumor activity, optically active isomers thereof, and pharmacologically acceptable salts thereof, wherein R represents lower alkyl; R¹ represents an α-amino acid residue, etc.; R² represents hydrogen, a hydroxyl-protecting group, etc.; and Y represents halogen, arylsulfonyloxy, etc.
    通式(1)和(2)代表的具有抗肿瘤活性的三氟甲基吡咯吲哚羧酸酯衍生物、其光学活性异构体及其药理上可接受的盐,其中R代表低级烷基;R¹代表α-氨基酸残基等;R²代表氢、羟基保护基等;Y代表卤素、芳基磺酰氧基等。
  • Novel Cyclopropapyrroloindole Derivative (AT-3510) Bearing Methoxycarbonyl and Trifluoromethyl Groups
    作者:Yasumichi Fukuda、Hirosuke Furuta、Yoshie Kusama、Hiroyuki Ebisu、Yasuo Oomori、Shiro Terashima
    DOI:10.1021/jm980668c
    日期:1999.4.22
    The seco-Cl 3-methoxycarbonyl-2-trifluoromethylcyclopropapyrroloindole (MCTFCPI) derivatives dl- and/or (S)-10 carrying various acyl moieties at the NG-position were synthesized along with their prodrugs (S)-12, and their antitumor activity was evaluated. Among these derivatives, AT-3510 [(S)-12m], the novel prodrug MCTFCPI derivative carrying a 5-(7-methoxybenzofuran-2-ylcarbonyl)aminoindole-2-carbonyl group at the NG-position, was found to exhibit more excellent antitumor activity against human tumor xenografts than the clinical trial candidates carzelesin (6) and KW-2189 (7) and cisplatin.
查看更多